J Vermeijden

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

Mirthe E. van der Valk, Marie‐Josée J. Mangen, Max Leenders et al. · Gut · 2012 · 491 citations · Full text

Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β‐blocker for prevention of variceal rebleeding

Ingrid L. Holster, Eric T.T.L. Tjwa, Adriaan Moelker et al. · Hepatology · 2015 · 220 citations · Full text

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Marieke J. H. Coenen, Dirk J. de Jong, Corine J. van Marrewijk et al. · Gastroenterology · 2015 · 193 citations · Full text

Inflammation, Autoimmune Disease, Hematology +7

Prevalence of Delayed Gastric Emptying in Diabetic Patients and Relationship to Dyspeptic Symptoms

Melvin Samsom, J Vermeijden, A. J. P. M. Smout et al. · Diabetes Care · 2003 · 147 citations · Full text

Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up

Mirthe E. van der Valk, Marie‐Josée J. Mangen, Mirjam Severs et al. · PLoS ONE · 2016 · 105 citations · Full text